- Home
- ILMN vs UHS Comparison
ILMN vs UHS Comparison
Compare ILMN & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- UHS
- Stock Information
- Founded
- ILMN 1998
- UHS 1978
- Country
- ILMN United States
- UHS United States
- Employees
- ILMN N/A
- UHS N/A
- Industry
- ILMN Medical Specialities
- UHS Hospital/Nursing Management
- Sector
- ILMN Health Care
- UHS Health Care
- Exchange
- ILMN Nasdaq
- UHS Nasdaq
- Market Cap
- ILMN 15.3B
- UHS 13.4B
- IPO Year
- ILMN 2000
- UHS N/A
- Fundamental
- Price
- ILMN $121.18
- UHS $228.99
- Analyst Decision
- ILMN Hold
- UHS Buy
- Analyst Count
- ILMN 15
- UHS 13
- Target Price
- ILMN $114.93
- UHS $231.62
- AVG Volume (30 Days)
- ILMN 2.1M
- UHS 619.5K
- Earning Date
- ILMN 10-30-2025
- UHS 10-27-2025
- Dividend Yield
- ILMN N/A
- UHS 0.35%
- EPS Growth
- ILMN N/A
- UHS 39.76
- EPS
- ILMN 4.46
- UHS 21.01
- Revenue
- ILMN $4,288,000,000.00
- UHS $16,992,503,000.00
- Revenue This Year
- ILMN N/A
- UHS $10.41
- Revenue Next Year
- ILMN $2.22
- UHS $4.93
- P/E Ratio
- ILMN $27.33
- UHS $10.91
- Revenue Growth
- ILMN N/A
- UHS 10.21
- 52 Week Low
- ILMN $68.70
- UHS $152.33
- 52 Week High
- ILMN $155.99
- UHS $229.76
- Technical
- Relative Strength Index (RSI)
- ILMN 66.82
- UHS 72.18
- Support Level
- ILMN $118.50
- UHS $215.64
- Resistance Level
- ILMN $126.00
- UHS $227.22
- Average True Range (ATR)
- ILMN 5.02
- UHS 6.68
- MACD
- ILMN 2.48
- UHS 0.98
- Stochastic Oscillator
- ILMN 84.61
- UHS 97.33
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.